All News

Cancer Network spoke with Dr. Jennifer A. Ligibel on the diet and exercise interventions to reduce breast cancer recurrences.

Underinsured patients use websites like GoFundMe to pay medical bills after being diagnosed with cancer, but many fundraising campaigns are unsuccessful.

A new orally active inverse agonist of estrogen-related receptor gamma (ERRү) called DN200434 shows promise with regard to the diagnosis and treatment of anaplastic thyroid cancer.

Previous laboratory research along with phase I and II trials suggested the combination of doxorubicin and sorafenib could offer improved outcomes in advanced hepatocellular cancer.

A new study found a low rate of cancer recurrence at the nipple-areola complex (NAC) in patients with breast cancer who underwent nipple-sparing mastectomy (NSM).

Researchers compared the demographics of patients in Oregon and Washington seeking medical aid in dying.

Could something as simple as synchronizing medicine refills at the pharmacy help improve survival in patients with breast cancer using endocrine therapy?

How much do you know about the incidence and screening of prostate cancer? Here's your chance to find out.

Researchers examined several studies of patients with Graves' Disease to see the prevalence of thyroid cancer in this population.

A new phase 1a/b study examined a total of 49 patients with solid tumors, including 34 with ovarian, fallopian tube, or primary peritoneal cancer, treated with a combination of the PARP 1/2 inhibitor pamiparib and the anti-PD-1 monoclonal antibody tislelizumab in several dose escalation cohorts.

A new study surveyed 1,246 patients on whether they'd be willing to share electronic health records and biospecimens for research.

Researchers assessed patients with biliary tract cancer (BTC) who underwent ctDNA testing  by means of a clinically available assay and analyzed samples using a 73-gene panel.

Many trials in the last decade that have led to FDA drug approvals didn't report on race and the ones that did were lacking in racial diversity.

A 22-year-old Caucasian woman presents with a four month history of pain, tenderness and swelling in her right breast. What's your diagnosis?

A new study looked at what methods were used to detect recurrences of human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma to see if surveillance guidelines recommended by the National Comprehensive Cancer Center were effective.

Laparoscopic treatment during pregnancy is becoming an option for more women.

Cancer Network spoke with Kelly Hunt, MD, professor and chair of the department of breast surgical oncology at the MD Anderson Cancer Center in Houston, about the role of surgery in metastatic breast cancer.

There are continued advances in the use of biomarkers to guide drug development and the more targeted delivery of medicine.

The U.S. Preventive Services Task Force released a new review of the benefits and harms of imaging-based screening for pancreatic cancer.

Despite the toll chemotherapy can take on the body, experts say it's possible for athletes to exercise while undergoing treatment for cancer.

Researchers looked at data from the Surveillance, Epidemiology, and End Results database to see if there has been any increase in the use of active surveillance or watchful waiting when it comes to low-risk prostate cancer.

How much do you know about the epidemiology and prognosis of ovarian cancer? Here's your chance to find out.

A 41-year-old woman presents with a palpable mass in her left breast. A lumpectomy is performed. What is your diagnosis?

In 2017, about half of physician directors at National Cancer Institute cancer centers received payments related to research, while a quarter received payments over $5,000 that were not related to research.

The United States Preventive Services Task Force issued a statement reaffirming its 2004 recommendation against screening for pancreatic cancer in asymptomatic adults.

A phase III trial found bevacizumab and pemetrexed were effective as a maintenance therapy, but researchers do not recommend it to treat non–small-cell lung cancer.